Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary). (Q33310987)

25 July 2017

title

Biological characterization of two xenografts derived from human CUPs (carcinomas of unknown primary). (English)

1 reference

25 July 2017

1 reference

Marie-Christine Mathieu

5

object named as

Marie-Christine Mathieu

0 references

Karim Fizazi

2

object named as

Karim Fizazi

1 reference

25 July 2017

Delphine Lequin

1

1 reference

25 July 2017

Saloua Toujani

3

1 reference

25 July 2017

Sylvie Souquère

4

1 reference

25 July 2017

Marie-Christine Mathieu

5

1 reference

25 July 2017

Pierre Hainaut

6

1 reference

25 July 2017

Alain Bernheim

7

1 reference

25 July 2017

Françoise Praz

8

1 reference

25 July 2017

Pierre Busson

9

1 reference

25 July 2017

language of work or name

English

0 references

publication date

18 December 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

225

1 reference

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

25 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Cancer of unknown primary site: missing primary or missing biology?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Sunitinib: from rational design to clinical efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Arrayed primer extension resequencing of mutations in the TP53 tumor suppressor gene: comparison with denaturing HPLC and direct sequencing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Metastases in carcinoma; analysis of 1000 autopsied cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

p53 gene mutation spectrum in human unknown primary tumors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-7-225

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2241840

Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18088404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18088404

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-7-225

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference